CCL18
CCL18 | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||||||||||||||||||
Wikidata | ||||||||||||||||||||||||||||||||||||||||
|
Chemokine (C-C motif) ligand 18 (CCL18) is a small
CCL18 is produced and secreted mainly by innate immune system, and has effects mainly on the adaptive immune system. It was previously known as Pulmonary and activation-regulated chemokine (PARC), dendritic cell (DC)-chemokine 1 (DC-CK1), alternative macrophage activation-associated CC chemokine-1 (AMAC-1), and macrophage inflammatory protein-4 (MIP-4).
Gene and protein structure
The gene of CCL18 is most similar to
Sources
CCL18 is produced mainly by
Chemotactic functions
Receptor
The classical receptors for chemokines are
Effector functions
CCL18 has a plethora of functions that have been characterized in vitro and in vivo. Strangely, CCL18 seems to play a part in both activation of the immune system and the induction of tolerance and homeostasis at steady-state conditions.
Immune activation
The production of CCL18 is induced by T-helper 2 type cytokines, namely IL-4 and IL-13. Coupled with the fact that CCL18 is highly expressed in patients with allergic asthma[18] and other hypersensitivity diseases,[6] CCL18 seems to play an important role for generating and maintaining a T-helper 2 (Th2) type response. Furthermore, the addition of CCL18 as an adjuvant for a malaria vaccine have shown efficacy, perhaps by recruiting immune cells to the site of vaccination.[19] Finally, CCL18 is expressed by dendritic cells in the germinal center of inflamed lymph nodes, and recruits naïve B-cells for antigen presentation.[20] Perhaps aberrant CCL18 expression is involved in the generation of chronic Th2 response, leading to asthma or arthritis.
Immunosuppression
In addition to immune-activating effects, CCL18 also has strong immunosuppressive effects. CCL18 induces immature dendritic cells to differentiate into an immunosuppressive dendritic cell that is capable producing CCL18 which attract T-cells, suppressing effector T-cell function, and generating T-regulatory cells by secreting large amounts of IL-10.[10][21] Furthermore, exposure to CCL18 by macrophages causes them to mature in the #M2 spectrum, which promotes immunosuppression and healing.[9]
Involvement in disease
Aberrant CCL18 expression is observed in many diseases, and it is thought that these abnormal expression patterns play a key role in these diseases.[6] This table shows a list of all the diseases that CCL18 is involved in.
Breast cancer
The most understood disease that CCL18 is involved in is in breast cancer, where CCL18 induces metastasis of breast cancer cells by binding to PITPNM3.[15] Perhaps CCL18, in breast cancers, is acting as an immunosuppressive cytokine by generating T-regulatory cells, generating immunosuppressive dendritic cells and macrophages, and recruiting effector T-cells to these dendritic cells and macrophages to abolish their anti-cancer functions and allowing the cancer to escape the immune system.
Autoimmunity and hypersensitivity
CCL18 is highly expressed in T-helper 2 mediated
References
- ^ a b c ENSG00000278167, ENSG00000278006 GRCh38: Ensembl release 89: ENSG00000275385, ENSG00000278167, ENSG00000278006 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ S2CID 6071325.
- ^ PMID 10671296.
- PMID 10049593.
- ^ PMID 15784687.
- ^ PMID 23102918.
- PMID 18959625.
- ^ PMID 22117697.
- ^ PMID 12646652.
- S2CID 4311897.
- PMID 22649201.
- ^ PMID 16670340.
- S2CID 8411960.
- ^ PMID 21481794.
- S2CID 24889239.
- ^ PMID 23999500.
- S2CID 46401617.
- PMID 12626578.
- PMID 11207283.
- PMID 21803856.
- PMID 15331393.
External links
- Human CCL18 genome location and CCL18 gene details page in the UCSC Genome Browser.